BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 27166650)

  • 21. Usefulness of Routine Coagulation Tests in Healthy Children Undergoing Elective Minor Surgery: a 12-Year Retrospective Study.
    Song J; Jung HW; Lee EH; Chang HK; Yoon HS
    Clin Lab; 2021 Dec; 67(12):. PubMed ID: 34910442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of an abnormal coagulation profile in children qualified for adenoidectomy/tonsilectomy].
    Kitszel A; Poznańska M; Krawczuk-Rybak M
    Otolaryngol Pol; 2007; 61(2):158-61. PubMed ID: 17668802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance and causes of abnormal preoperative coagulation test results in children.
    Samková A; Blatný J; Fiamoli V; Dulíček P; Pařízková E
    Haemophilia; 2012 May; 18(3):e297-301. PubMed ID: 21967473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy.
    Asaf T; Reuveni H; Yermiahu T; Leiberman A; Gurman G; Porat A; Schlaeffer P; Shifra S; Kapelushnik J
    Int J Pediatr Otorhinolaryngol; 2001 Dec; 61(3):217-22. PubMed ID: 11700191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
    Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
    Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should healthy children who will undergo minor surgery be screened for coagulation disorder?
    Kang S; Yoon HS; Lee EH
    Pediatr Hematol Oncol; 2016 May; 33(4):233-8. PubMed ID: 27166650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.
    Kamal AH; Tefferi A; Pruthi RK
    Mayo Clin Proc; 2007 Jul; 82(7):864-73. PubMed ID: 17605969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory investigations for bleeding disorders.
    Hayward CP; Moffat KA; Liu Y
    Semin Thromb Hemost; 2012 Oct; 38(7):742-52. PubMed ID: 23011792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significance of blood tests prior to adenoidectomy].
    Schwaab M; Hansen S; Gurr A; Dazert S
    Laryngorhinootologie; 2008 Feb; 87(2):100-6. PubMed ID: 17963191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thrombinography: towards a globalization of coagulation tests].
    Péters P; Gothot A
    Rev Med Liege; 2009 Apr; 64(4):199-203. PubMed ID: 19514539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of deranged activated partial thromboplastin time for anaesthesia and surgery.
    Loizou E; Mayhew DJ; Martlew V; Murthy BVS
    Anaesthesia; 2018 Dec; 73(12):1557-1563. PubMed ID: 30315725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Evaluation of Bleeding and Bruising in Primary Care.
    Neutze D; Roque J
    Am Fam Physician; 2016 Feb; 93(4):279-86. PubMed ID: 26926815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy.
    Cugno M; Gualtierotti R; Tedeschi A; Meroni PL
    Autoimmun Rev; 2014 Jan; 13(1):40-8. PubMed ID: 23954454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art.
    Adcock DM; Moore GW; Montalvão SL; Kershaw G; Gosselin RC
    Semin Thromb Hemost; 2023 Sep; 49(6):571-579. PubMed ID: 36055261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests.
    Favaloro EJ
    Am J Hematol; 2020 Jan; 95(1):117-128. PubMed ID: 31674066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exploration of hemostasis disorders in children (excluding the neonatal period)].
    Bader-Meunier B; Dreyfus M
    Arch Pediatr; 1999 Oct; 6(10):1086-91. PubMed ID: 10544786
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.